Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2017-004128-32-CZ
EUCTR2017-004128-32-CZ
Active, not recruiting
Phase 1

Imaging of the prostate tumors using PET/CT and PET/MRI with the ligand of the prostatic specific membrane antigene 68Ga-PSMA-11

Fakultní nemocnice Plzen0 sites200 target enrollmentNovember 20, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsprostatic carcinoma higly suspected or its staging or restagingTherapeutic area: Diseases [C] - Male diseases of the urinary and reproductive systems [C12]

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
prostatic carcinoma higly suspected or its staging or restaging
Sponsor
Fakultní nemocnice Plzen
Enrollment
200
Status
Active, not recruiting
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 20, 2017
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Male

Investigators

Sponsor
Fakultní nemocnice Plzen

Eligibility Criteria

Inclusion Criteria

  • •prostatic carcinoma higly suspected or its staging or restaging in male older than 18, WHO performance status 1 or 2
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 100
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range 100

Exclusion Criteria

  • •WHO performance status 3 or 4, renal mpairment

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Evaluation of new PET tracer, [F-18]Florastamin for diagnosing prostate cancer: Phase I clinical trial
KCT0004817FutureChem10
Active, not recruiting
Not Applicable
Diagnostic imaging in prostate cancer (as in tumours with accelerated menbrane turn-over)by F-18 Fluoro-metil-choline PET/CTpatients with prostate cancer istologically provenMedDRA version: 14.1Level: SOCClassification code 10038359Term: Renal and urinary disordersSystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 14.1Level: SOCClassification code 10022891Term: InvestigationsSystem Organ Class: 10022891 - InvestigationsTherapeutic area: Diseases [C] - Cancer [C04]
EUCTR2008-003337-24-ITCENTRO DI RIFERIMENTO ONCOLOGICO DI BASILICATA
Recruiting
Not Applicable
Diagnostic Performance of PET Imaging for Prostate Specific Membrane Antigen (PSMA)Prostate cancer
JPRN-UMIN000037697Osaka University Graduate School of Medicine250
Recruiting
Not Applicable
Evaluation of new PET tracer, [F-18]Florastamin for diagnosing prostate cancerNeoplasms
KCT0003924Korea Cancer Center Hospital6
Completed
Phase 1
Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE CollaborationProstate Cancer
NCT00987376Mayo Clinic8